Incorporating overrunning data into the analysis of both primary and secondary endpoints in a sequential trial (Q3511591)
From MaRDI portal
!
This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use the normal view instead:
scientific article; zbMATH DE number 5299667
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Incorporating overrunning data into the analysis of both primary and secondary endpoints in a sequential trial |
scientific article; zbMATH DE number 5299667 |
Statements
11 July 2008
0 references
additional data
0 references
arm-specific analysis
0 references
clinical trials
0 references
interim analysis
0 references
patient allocation
0 references
secondary endpoints
0 references
stopping boundaries
0 references
0.8815826177597046
0 references
0.791871190071106
0 references
0.7683913111686707
0 references
0.7576195597648621
0 references
0.7369875907897949
0 references
